Dr. Tracy Beth Høeg, the high-ranking official overseeing the FDA’s division for over-the-counter and prescription drugs, has announced her departure from the agency. Her exit comes just days after the sudden resignation of the FDA’s chief, signaling a profound period of instability for the nation’s primary public health regulatory body. A Period of Unprecedented Transition…
The U.S. Food and Drug Administration (FDA) dismissed senior official Dr. Tracy Beth Hoeg this week, marking a significant leadership shift within the nation’s top drug regulatory body. Dr. Hoeg, a prominent figure known for her public commentary on public health policy, confirmed her departure on social media, noting that the agency provided no specific…
President-elect Donald Trump is reportedly moving to replace Dr. Marty Makary as the Commissioner of the Food and Drug Administration (FDA) following internal friction regarding key public health policies. The potential dismissal comes as the incoming administration seeks to overhaul federal health agencies, despite Dr. Makary’s previous alignment with the “Make America Healthy Again” movement….
